Alissa Davis1, Anindita Dasgupta, Dawn Goddard-Eckrich, Nabila El-Bassel. 1. From the *HIV Center, Division of Gender, Sexuality, and Health, New York State Psychiatric Institute and Columbia University Medical Center; and †Social Intervention Group, School of Social Work, Columbia University, New York, NY.
Abstract
BACKGROUND: The United States has a large community supervision population, a growing number of whom are women. Trichomonas vaginalis infection is strongly associated with an increased risk of human immunodeficiency virus (HIV) acquisition and transmission, particularly among women, but there is a paucity of research on HIV and T. vaginalis co-infection among women under community supervision. METHODS: This article examines the prevalence of T. vaginalis infection and T. vaginalis and HIV coinfection at baseline among women under community supervision in New York City. It also examines the 12-month outcomes of women treated for T. vaginalis. Women received biological tests for HIV and T. vaginalis at baseline and 12 months follow-up. RESULTS: Of the 333 women tested for sexually transmitted infections, 77 women (23.1%) tested positive for T. vaginalis at baseline and 44 (13.3%) were HIV positive. Human immunodeficiency virus-positive women had significantly higher rates of T. vaginalis infection than HIV-negative women (36.4% vs 21.3%, P ≤ 0.05). Sixteen women (4.8%) were coinfected with T. vaginalis and HIV. Of the 77 women who were positive for T. vaginalis infection at baseline, 58 (75.3%) received treatment by a health care provider. Of those who received treatment, 17 (29.3%) tested positive for T. vaginalis at the 12-month follow-up. CONCLUSIONS: Given the high prevalence of T. vaginalis among this sample of women, particularly among HIV-positive women, and high levels of reinfection or persistent infection, screening for T. vaginalis among women under community supervision may have a substantial impact on reducing HIV acquisition and transmission among this high-risk population.
BACKGROUND: The United States has a large community supervision population, a growing number of whom are women. Trichomonas vaginalis infection is strongly associated with an increased risk of human immunodeficiency virus (HIV) acquisition and transmission, particularly among women, but there is a paucity of research on HIV and T. vaginalis co-infection among women under community supervision. METHODS: This article examines the prevalence of T. vaginalis infection and T. vaginalis and HIV coinfection at baseline among women under community supervision in New York City. It also examines the 12-month outcomes of women treated for T. vaginalis. Women received biological tests for HIV and T. vaginalis at baseline and 12 months follow-up. RESULTS: Of the 333 women tested for sexually transmitted infections, 77 women (23.1%) tested positive for T. vaginalis at baseline and 44 (13.3%) were HIV positive. Human immunodeficiency virus-positive women had significantly higher rates of T. vaginalis infection than HIV-negative women (36.4% vs 21.3%, P ≤ 0.05). Sixteen women (4.8%) were coinfected with T. vaginalis and HIV. Of the 77 women who were positive for T. vaginalis infection at baseline, 58 (75.3%) received treatment by a health care provider. Of those who received treatment, 17 (29.3%) tested positive for T. vaginalis at the 12-month follow-up. CONCLUSIONS: Given the high prevalence of T. vaginalis among this sample of women, particularly among HIV-positive women, and high levels of reinfection or persistent infection, screening for T. vaginalis among women under community supervision may have a substantial impact on reducing HIV acquisition and transmission among this high-risk population.
Authors: Ank E Nijhawan; Alison K DeLong; David D Celentano; Robert S Klein; Jack D Sobel; Denise J Jamieson; Susan Cu-Uvin Journal: Sex Transm Dis Date: 2011-12 Impact factor: 2.830
Authors: Laura H Bachmann; Marcia M Hobbs; Arlene C Seña; Jack D Sobel; Jane R Schwebke; John N Krieger; R Scott McClelland; Kimberly A Workowski Journal: Clin Infect Dis Date: 2011-12 Impact factor: 9.079
Authors: Nabila El-Bassel; Louisa Gilbert; Dawn Goddard-Eckrich; Mingway Chang; Elwin Wu; Tim Hunt; Matt Epperson; Stacey A Shaw; Jessica Rowe; Maria Almonte; Susan Witte Journal: PLoS One Date: 2014-11-05 Impact factor: 3.240
Authors: Eshan U Patel; Charlotte A Gaydos; Zoe R Packman; Thomas C Quinn; Aaron A R Tobian Journal: Clin Infect Dis Date: 2018-07-02 Impact factor: 9.079
Authors: Oscar Holmström; Nina Linder; Harrison Kaingu; Ngali Mbuuko; Jumaa Mbete; Felix Kinyua; Sara Törnquist; Martin Muinde; Leena Krogerus; Mikael Lundin; Vinod Diwan; Johan Lundin Journal: JAMA Netw Open Date: 2021-03-01